All-trans retinoic acid alleviates transmissible gastroenteritis virus-induced intestinal inflammation and barrier dysfunction in weaned piglets

Background Transmissible gastroenteritis virus(TGEV)is one of the main pathogens causing severe diarrhea of pig-lets.The pathogenesis of TGEV is closely related to intestinal inflammation.All-trans retinoic acid(ATRA)is the main active metabolite of vitamin A,which has immunomodulatory and anti-inflammatory properties.However,it is unclear whether ATRA can alleviate TGEV-induced intestinal inflammation and barrier dysfunction in piglets.This study aimed to investigate the effects of ATRA on growth performance,diarrhea,intestinal inflammation and intesti-nal barrier integrity of TGEV-challenged piglets.Methods In a 19-d study,32 weaned piglets were randomly divided into 4 treatments:Control group(basal diet),TGEV group(basal diet+TGEV challenge),TGEV+ATRA5 group(basal diet+5 mg/d ATRA+TGEV challenge)and TGEV+ATRA15 group(basal diet+15 mg/d ATRA+TGEV challenge).On d 14,piglets were orally administered TGEV or the sterile medium.Results Feeding piglets with 5 and 15 mg/d ATRA alleviated the growth inhibition and diarrhea induced by TGEV(P<0.05).Feeding piglets with 5 and 15 mg/d ATRA also inhibited the increase of serum diamine oxidase(DAO)activ-ity and the decrease of occludin and claudin-1 protein levels in jejunal mucosa induced by TGEV,and maintained intestinal barrier integrity(P<0.05).Meanwhile,5 mg/d ATRA feeding increased the sucrase activity and the expres-sions of nutrient transporter related genes(GLUT2 and SLC7A1)in jejunal mucosa of TGEV-challenged piglets(P<0.05).Furthermore,5 mg/d ATRA feeding attenuated TGEV-induced intestinal inflammatory response by inhibit-ing the release of interleukin(IL)-1β,IL-8 and tumor necrosis factor-α(TNF-α),and promoting the secretion of IL-10 and secretory immunoglobulin A(sIgA)(P<0.05).Feeding 5 mg/d ATRA also down-regulated the expressions of Toll-like receptors and RIG-I like receptors signaling pathway related genes(TLR3,TLR4,RIG-I,MyD88,TRIF and MAVS)and the phosphorylation level of nuclear factor-κB-p65(NF-κB p65),and up-regulated the inhibitor kappa B alpha(IκBα)protein level in jejunal mucosa of TGEV-challenged piglets(P<0.05).Conclusions ATRA alleviated TGEV-induced intestinal barrier damage by inhibiting inflammatory response,thus improving the growth performance and inhibiting diarrhea of piglets.The mechanism was associated with the inhibi-tion of NF-κB signaling pathway mediated by TLR3,TLR4 and RIG-I.

Development of TaqMan-based Real-time PCR Assay for Detecting Transmissible Gastroenteritis Virus and Its Application in Vaccine Evaluation

[Objective] This study aimed to establish a TaqMan-based real-time PCR assay for detecting transmissible gastroenteritis virus （TGEV）. [Method] Primers and a probe were designed according to the conserved sequence of N gene in TGEV genome. After gradient dilution, the recombinant plasmid harboring the N gene was used as a standard for real-time PCR assay to establish the standard curve. [Re- sult] The results showed that the established real-time PCR assay exhibited a good linear relationship within the range of 102-10^10 copies/ul; the correlation coefficient was above 0.99 and the amplification efficiency ranged from 90% to 110%. The de- tection limit of real-time PCR assay for TGEV was 10 copies/μl, suggesting a high sensitivity; there was no cross reaction with other porcine viruses, indicating a good specificity; coefficients of variation within and among batches were lower than 3%, suggesting a good repeatability. The established real-time PCR method could be ap- plied in quantitative analysis and evaluation of the immune efficacy of TGEV vac- cines and detection of TGEV in clinical samples. [Conclusion] The TaqMan-based real-time PCR assay established in this study is highly sensitive and specific, which can provide technical means for the epidemiological survey of TGEV, development of TGEV vaccines and investigation of the pathogenesis of TGE.

Complete Genomic Sequence of Transmissible Gastroenteritis Virus TS and 3' End Sequence Characterization Following Cell Culture

The complete genome sequence of transmissible Gastroenteritis virus (TGEV) strain TS, previously isolated from Gansu province, was cloned and compared with published sequence data from other TGEV strains. Phylogenetic tree analysis based on the amino acid and nucleotide sequences of the S gene showed that the TGEV strains were divided into 3 clusters. TGEV TS showed a close evolutionary relationship to the American Miller cluster but had a 5' non-translated region (NTR) sequence closely related to the American Purdue cluster. Continued culture in different cell types indicated that TGEV TS virulence could be attenuated after fifty passages in Porcine kidney (PK-15) cells, and that the Porcine kidney cell line IB-RS-2 (IBRS) was not suitable for culture of the TGEV strain TS.

Cloning and Identification of S Gene from Chinese Isolate TH-98 of Transmissible Gastroenteritis Virus

Chinese isolate of transmissible gastroenteritis virus(TGEV)was propagated and harvested in swine testicle(ST)cells.Two pairs of primers were designed according to the published sequence with Oligo 4.1 and DNasis softwares.The products of RT-PCR were named Sa and Sb,of 2.3kb and 2.1kb respectively.Sa was inserted in EcoR I and Kpn I sites after Sb was cloned in Kpn I and Pst I sites of the same pUC18 plasmid.The recombinant designated pUC-S was verified and analyzed by corresponding restriction endonuclease(RE)and nested PCR on the basis of genetic sites of S gene and physical map of pUC18 plasmid,which was identified as S gene from Chinese isolate of TGEV.

Cloning and Homology Comparison of S Gene for Isolate TH-98 of Porcine Transmissible Gastroenteritis Virus

TH-98 isolate of transmissible gastroenteritis virus (TGEV) was propagated and harvested on swine testicle (ST) monolayer cell. Two pairs of primers were designed to amplify S gene by RT-PCR according to the published sequence of TGEV'S gene cDNA with Oligo version 4.1 and DNasis software. The products of PCR were named Sa and Sb, of 2.3 kb and 2.1 kb respectively. Sa was inserted in EcoR I and Kpn I sites after Sb was cloned in Kpn I and Pst I multiple cloning sites of the same pUC18 plasmid. The recombinant pUC-S plasmid was identified and analyzed by corresponding restriction endonuclease and nested PCR on the basis of the genetic sites of S gene and pUC18 plasmid, which was identified as S gene of TGEV. Recombinant pUC-S was sequenced and analyzed in comparison with the other strains. Gene sequence comparison indicated that TH-98 shared 99, 97, 98, 97 and 94% identities with Purdue-115(US), Miller(US), TO14(Japan), FS772(British), 96-1933(British), respectively, their deduced amino acid homology was 99, 97, 97, 96 and 93% correspondingly. In addition, the analysis report verified that pUC-S owned a complete open reading frame (ORF) including initiation codon, signal sequences, remaining sequences and termination codon as well. Therefore, the results affirmed that S gene of TGEV TH-98 was extremely conservative.

黄连生物碱对TGEV诱导的ST细胞炎症反应的调节作用

分别用质量浓度为100、50、25μg/m L的黄连生物碱(ACC)处理猪传染性胃肠炎病毒(TGEV)感染的猪睾丸细胞(ST),采用噻唑蓝(MTT)法检测细胞的活力;采用硝酸还原酶法检测NO含量;采用比色法检测总一氧化氮合成酶(TNOS)和诱导型一氧化氮合成酶(i NOS)活性;采用荧光定量PCR检测TNF-α、IL-1β、IL-6、IL-10等炎症基因的表达。结果表明:100、50μg/mL的ACC可极显著提高TGEV感染的ST细胞的存活率,25μg/mL的ACC可显著提高TGEV感染的ST细胞存活率;TGEV感染后ST细胞NO含量急剧升高,100、50μg/mL的ACC可极显著降低ST细胞TNOS和i NOS活性,25μg/mL ACC可显著降低TNOS和i NOS活性;ACC可极显著下调ST细胞TNF-α、IL-1β、IL-6、IL-10m RNA的表达水平。表明黄连生物碱可以降低TGEV诱导的ST细胞的炎症反应,缓解病毒对细胞的损伤。

PEDV、TGEV与PDCoV S蛋白表位基因三联疫苗的构建及其鉴定

[目的]构建一种同时预防猪流行性腹泻病毒(PEDV)、猪传染性胃肠炎病毒(TGEV)和猪德尔塔冠状病毒(PDCoV)的三联表位疫苗,以预防上述病原导致的猪的相关疾病。[方法]本研究运用免疫信息学在线软件对3种猪肠道冠状病毒(SeCoVs)的S蛋白B、T细胞表位进行预测分析,构建新的表位肽段,命名为PPT,通过ExPASy、VaxiJen、TMHMM、SOPMA、SOLpro和AlphaFlod2等在线软件对PPT进行生物信息学分析,并利用C-IMMSIM在线软件对其免疫反应进行模拟。通过T2A将PPT与PEDV的COE序列、TGEV的SAD序列及PDCoV的CTD序列连接并构建至真核表达载体pEGFP-N1,经PCR和双酶切鉴定正确后,将获得的重组质粒转染HEK293A细胞,经DAPI染色、CCK8、RT-PCR及Western blotting试验验证重组质粒在体外表达情况。[结果]构建的表位蛋白PPT由17条表位肽段组成,经生物信息学软件分析,该蛋白为非跨膜蛋白,结构稳定,具有抗原性和可溶性,亲水性高,无过敏性。C-IMMSIM结果显示,PPT能引起机体树突状细胞(DC)增加,B、T细胞免疫反应,刺激免疫球蛋白IgG、IgM和细胞因子γ-干扰素(IFN-γ)、白细胞介素-2(IL-2)水平升高。重组质粒经PCR和双酶切鉴定结果显示,分别在3359、2375、1064、944、764和467 bp出现特异性目的条带,与预期相符;重组质粒转染HEK293A细胞后,可见绿色荧光;RT-PCR扩增分别在3359、2375、1064、944、764和467 bp处获得与目的基因大小相符的条带;CCK-8检测结果表明,重组质粒对细胞均无明显毒性作用;Western blotting检测结果显示,分别在31.7、16.1、37.9和27.5 ku处出现与目的蛋白分子质量大小一致的条带,重组质粒成功在HEK293A细胞中表达。[结论]本研究基于计算机软件分析设计的PPT表位蛋白成功构建三联疫苗,且在体外表达,为评价PEDV-TGEV-PDCoV三联表位疫苗的免疫效果提供依据。

猪氨基肽酶N病毒结合受体核心区对TGEV在ST细胞中复制影响的研究

为研究与猪传染性胃肠炎病毒(TGEV)结合的猪氨基肽酶N(pAPN)受体核心区对TGEV复制以及细胞功能的影响,本研究检索并分析pAPN与TGEV的结合位点,结果显示,敲除pAPN aa668~aa963对其酶活性无影响。因此,利用CRISPR/Cas9技术构建pAPN与TGEV结合位点敲除细胞系,经PCR和western blot鉴定结果显示,正确构建一株敲除pAPN aa668~aa963的ST细胞系,即敲除pAPN 15-21外显子,命名为KO-ST-15。采用CCK-8和细胞划痕方法检测KO-ST-15细胞的增殖和细胞迁移活性,结果显示,敲除pAPN 15-21外显子对ST细胞增殖和迁移活性均无显著影响。利用RT-qPCR和IFA检测KO-ST-15感染TGEV后病毒复制拷贝数和N蛋白的表达,结果显示,敲除pAPN 15-21外显子可极显著抑制TGEV在ST细胞系中的复制(P<0.001)。利用RT-qPCR检测KO-ST-15感染TGEV后炎症相关基因转录水平变化,结果显示,TGEV感染后KO-ST-15中的IL-6、IL-8和NLRP3(NOD-like receptor protein 3)mRNA转录水平无显著变化,但RIG-I和MDA5的转录水平显著上调(P<0.05)。上述结果首次表明,敲除pAPN15-21外显子能够极显著抑制TGEV在ST细胞中的复制,但细胞KO-ST-15的正常生理功能无变化,TGEV不能进入敲除pAPN 15-21外显子的细胞中引起炎症反应,该结果为进一步培育抗病育种猪提供参考依据和候选方案。

Coronavirus transmissible gastroenteritis virus antagonizes the antiviral effect of the microRNA miR-27b via the IRE1 pathway

Although the functional parameters of micro RNAs(mi RNAs)have been explored to some extent,the roles of these molecules in coronavirus infection and the regulatory mechanism of mi RNAs in virus infection are still unclear.Transmissible gastroenteritis virus(TGEV)is an enteropathgenic coronavirus and causes high morbidity and mortality in suckling piglets.Here,we demonstrated that microRNA-27b-3p(miR-27b-3p)suppressed TGEV replication by directly targeting porcine suppressor of cytokine signaling 6(SOCS6),while TGEV infection downregulated miR-27b-3p expression in swine testicular(ST)cells and in piglets.Mechanistically,the decrease of miR-27b-3p expression during TGEV infection was mediated by the activated inositolrequiring enzyme 1(IRE1)pathway of the endoplasmic reticulum(ER)stress.Further studies showed that when ER stress was induced by TGEV,IRE1 acted as an RNase activated by autophosphorylation and unconventionally spliced m RNA encoding a potent transcription factor,X-box-binding protein 1(Xbp1s).Xbp1s inhibited the transcription of miR-27 and ultimately reduced the production of miR-27b-3p.Therefore,our findings indicate that TGEV inhibits the expression of an anti-coronavirus micro RNA through the IRE1 pathway and suggest a novel way in which coronavirus regulates the host cell response to infection.

Effects of Different Alkaloids in Coptis chinensis on Inhibiting TGEV Proliferation

[Objectives]To study the effects of different alkaloids in Coptis chinensis on inhibiting the proliferation of Transmissible gastroenteritis virus(TGEV).[Methods]The components and content of the main alkaloids in the extract of C.chinensis were analyzed.The main alkaloids were selected as drugs to inhibit the proliferation of TGEV.The maximum non-toxic concentration of Columbamine,Jatrorrhizine,Epiberberine,Coptisine,Palmatine,and Berberine was screened.The protective rate of each drug on TGEV-infected ST cells was determined,and the transcriptional inhibitory effect of the drug on TGEV N gene was detected by fluorescent quantitative PCR.[Results]The extract of C.chinensis mainly contains 6 alkaloids:Columbamine,Jatrorrhizine,Epiberberine,Coptisine,Palmatine,and Berberine,accounting for 2.03%,8.88%,9.21%,15.07%,14.63%,and 50.18%,respectively.In the range of the safe concentration,Jatrorrhizine,Palmatine,and Coptisine had better protective effects on ST cells infected with TGEV;compared with the Columbamine group,the cell protection rate was significantly different(P<0.05);compared with the Berberine group,the difference was extremely significant(P<0.01).The Coptisine and Palmatine groups had significant inhibitory effects on the transcription of TGEV N gene,and the difference was extremely significant compared with the virus group(P<0.05).[Conclusions]Jatrorrhizine and Palmatine in C.chinensis are the main components to inhibit the proliferation of TGEV.

猪传染性胃肠炎病毒(TGEV)S蛋白的原核表达与纯化

为制备高致病性的TGEV毒株重组S蛋白,试验将重组质粒pET28a-TGEV-S2、pET28a-TGEV-S3,转化至E.coli BL21(DE3)表达菌株,设置不同的诱导温度、IPTG浓度和诱导时长对其进行表达条件的优化,并使用纯化试剂盒将其纯化,采用SDS-PAGE和Western blot进行蛋白鉴定。结果表明,重组TGEV毒株S蛋白的分子量分别约为28 kDa、30 kDa,在不同诱导条件下均以包涵体形式存在,在28℃条件下以终浓度为1 mmoL·L^(-1)IPTG诱导4 h表达量达到最高。结果表明:试验成功制备了TGEV重组S蛋白,为TGEV抗体检测试剂盒和基因工程疫苗、检测试剂的研究奠定了基础。

PEDV、TGEV、PoRV 3种猪病毒性腹泻病毒的流行现状及控制策略

引起猪病毒性腹泻的病原主要有猪流行性腹泻病毒(porcine epidemic diarrhea virus,PEDV)、猪传染性胃肠炎病毒(transmissible gastroenteritis virus,TGEV)及猪轮状病毒(porcine rotarvirus,PoRV),临床均以呕吐、严重腹泻和脱水为特征,哺乳仔猪发病率和病死率较高,后备猪、母猪或育肥猪呈一过性腹泻,发病率较低。特别是自2010年以来,PEDV变异毒株的流行已对全球的生猪产业造成严重影响,而已有的防控措施已经不能应对新的流行态势。近年来,针对PEDV、TGEV、PoRV的毒株流行变化及防控措施研究的较多,许多新技术、新方法已应用于3种病原的控制。作者基于当前3种病毒的遗传变异分析和流行现状,从饲养管理、免疫预防、中药疗法、干扰疗法、特异疗法及返饲疗法等方面对防控措施进行综述,以期为猪病毒性腹泻的防控提供科学依据。

山东省猪腹泻病例中PEDV、TGEV和PRV的感染调查与分析

为了解山东省规模化猪场由猪流行性腹泻病毒(PEDV)、猪传染性胃肠炎病毒(TGEV)和猪伪狂犬病毒(PRV)引起猪病毒性腹泻的流行情况,自2014年1月至2016年12月,对来自山东省各地规模化猪场的猪腹泻病料(共3 035份)进行PCR检测。结果显示,PEDV、PRV和TGEV阳性率分别为67.49%、9.33%和3.29%;3年间,PEDV阳性率在2014年第四季度最低,为48.15%,2015年第四季度阳性率最高,为88.57%,2016年各季度阳性率相对2015年呈波动下降趋势;TGEV阳性率在2014年第四季度最高,为18.52%,2015年第三季度阳性率为15.38%,2016年第一季度阳性率为6.67%,其他季度未检测出阳性病料;PRV阳性率在2016年第二季度最高,为15.68%,除2014年第一季度未检出阳性病料外,2014年第二季度阳性率最低,为2.56%。通过对69份被动送检的病料进行PEDV、TGEV和PRV混合感染检测发现,这部分病料中PEDV、TGEV、PRV阳性率分别为86.96%、5.80%和37.68%;总单独感染率为69.57%,PEDV、TGEV和PRV单独感染率分别为57.97%、1.45%和10.14%;总混合感染率为30.43%,PEDV/PRV、PEDV/TGEV和TGEV/PRV混合感染率分别为26.09%、2.90%和1.45%;总单独感染率比总混合感染率高。结果表明,山东省存在PEDV、PRV和TGEV 3种病毒流行,存在PEDV/TGEV、TGEV/PRV和PEDV/PRV的混合感染,混合感染中主要为PEDV/PRV混合感染,不存在PEDV/PRV/TGEV的混合感染。目前PEDV是引起山东省猪病毒性腹泻的主要病因,本试验结果可为山东省猪病毒性腹泻的诊断和控制提供参考。

PEDV、TGEV、PDCoV、PRoV多重TaqMan荧光定量RT-PCR检测方法的建立及应用

为建立鉴别检测猪流行性腹泻病毒(PEDV)、猪传染性胃肠炎病毒(TGEV)、猪德尔塔冠状病毒(PDCoV)和猪轮状病毒(PRoV)的方法,本研究分别针对PEDVN基因、TGEVM基因、PDCoVM基因和PRoVVP6基因设计特异性引物和TaqMan探针,经过优化反应条件,建立了同时检测4种病毒的多重TaqMan荧光定量RT-PCR方法。结果显示,该方法仅特异性扩增PEDV、TGEV、PDCoV和PRoV,与猪其它主要病毒无交叉反应,特异性较强;对PEDV、TGEV、PDCoV和PRoV的质粒标准品的最低检出限分别为2.06×10^2拷贝/μL、2.06×10^2拷贝/μL、2.06×10^1拷贝/μL、2.06×10^3拷贝/μL,具有较高敏感性;组内与组间变异系数均小于1.1%,具有良好的重复性。应用该方法和普通多重RT-PCR检测临床采集的243份腹泻病料样品,两者的符合率为96.71%。本研究建立的方法为临床PEDV、TGEV、PDCoV、PRoV的鉴别检测及流行病学调查提供了一种快速、特异、敏感、高效的技术手段。

携带TGEV DNA疫苗减毒沙门氏菌的构建及安全性与免疫性分析

【目的】探讨以减毒沙门氏菌为载体,进行TGEV DNA疫苗口服免疫可行性。【方法】通过RT-PCR扩增TGEV四川株(SC-H)S基因5’端约2.1 kb的主要抗原位点片段,将其插入真核表达载体pVAX1,构建重组质粒pVAX-S,体外转染COS-7细胞,间接免疫荧光检测S基因表达。通过电转化将pVAX-S转入减毒鼠伤寒沙门氏菌SL7207,构建SL7207(pVAX-S)重组菌,并在体外感染小鼠腹腔巨噬细胞,以RT-PCR、间接免疫荧光检测细胞内S基因的转录与表达情况。将SL7207(pVAX-S)重组菌以5×108、1×109、2×109CFU剂量口服接种BALB/c小鼠,分析其安全性,并以1×109CFU剂量的重组菌3次免疫BALB/c小鼠,通过间接ELISA检测免疫小鼠的血清IgG与肠道粘膜IgA抗体。【结果】成功构建重组质粒pVAX-S,且重组质粒能在COS7细胞中表达。重组菌SL7207(pVAX-S)感染巨噬细胞后检测到目的基因的转录、表达。小鼠口服接种不同剂量重组菌,具有良好的安全性。免疫小鼠于二免后两周可检测到针对TGEV S蛋白的特异性血清IgG与肠道粘膜IgA抗体,且三免后两周与SL7207(pVAX1)空载体免疫组间分别存在显著性差异(P<0.05)和极显著性差异(P<0.01)。【结论】携带TGEV DNA疫苗的减毒沙门氏菌小鼠试验显示了良好的免疫原性与安全性。

猪传染性胃肠炎病毒(TGEV)对猪小肠黏膜上皮细胞活性的影响

观察猪传染性胃肠炎病毒对猪小肠黏膜上皮细胞Na+-K+-ATP酶、Ca2+-Mg2+-ATP酶活性,细胞增殖和凋亡的影响。将猪传染性胃肠炎病毒接种于体外培养猪小肠黏膜上皮细胞24、48和72 h后,检测细胞的ATP酶(Na+-K+-ATP酶、Ca2+-Mg2+-ATP酶)活性,MTT法检测细胞增殖能力,流式细胞仪测定细胞周期,PI染色法检测细胞凋亡。与空白组相比较,试验组小肠黏膜上皮细胞的Na+-K+-ATP酶活性降低(P<0.05),Ca2+-Mg2+-ATP酶活性降低(P>0.05),细胞增殖能力降低,S期细胞比例降低,细胞凋亡明显。猪传染性胃肠炎病毒可以降低猪小肠黏膜上皮细胞的Na+-K+-ATP酶活性、Ca2+-Mg2+-ATP酶活性,减弱细胞的增殖能力并引起细胞凋亡。

基于单链置换的环介导间接PCR鉴别PEDV、TGEV方法的建立及应用

【目的】猪病毒性腹泻主要是由猪流行性腹泻病毒(PEDV)和猪传染性胃肠炎病毒(TGEV)所引起的一种急性肠道传染病,临床上以呕吐、腹泻、脱水、高发病率和死亡率为主要特征。PEDV与TGEV同属α冠状病毒,可以感染各年龄段猪只,尤其对仔猪的危害最为严重,可导致大量仔猪死亡,给养殖业造成严重经济损失。由于PEDV和TGEV感染在临床症状、病理变化和流行病学上极为相似,临床上很难区分,因此,建立一种高效、特异的临床鉴别诊断方法对于预防病毒性腹泻的爆发流行具有重要意义。本试验旨在建立猪流行性腹泻病毒(PEDV)和猪传染性胃肠炎病毒(TGEV)环介导间接PCR检测方法,用于猪病毒性腹泻的病原学鉴别诊断。【方法】根据Gen Bank数据库中PEDV和TGEV基因组序列信息,在对两种病毒基因序列同源性比较的基础上,分别选取PEDV和TGEV核蛋白(N)基因序列的一段高度保守区,设计两条序列相邻的特异性探针,标记于不同大小的TOC1基因片段两端,作为特异性标记的报告基因。此报告基因与待测靶标基因经杂交、环化后,采用1对引物反向PCR扩增报告基因,建立PEDV/TGEV鉴别诊断方法,扩增片段大小分别为404、252bp。【结果】该方法特异性好,可单独或同时检测PEDV和TGEV,与猪圆环病毒2型(PCV2)、猪A型轮状病毒(RAV)、猪繁殖与呼吸综合征病毒(PRRSV)、猪瘟病毒(CSFV)、猪伪狂犬病毒(PRV)和猪细小病毒(PPV)等常见猪源性病毒无交叉扩增;检测灵敏度高,对PEDV和TGEV的最低极限浓度分别为1.6和8 pg·μL-1的核酸样品,两种病原的同时检测不影响检测灵敏度;采用环介导间接PCR、常规RT-PCR和Sybr Green实时PCR对157份临床样本进行比较检测,3种方法的PEDV检出率分别为33.76%、21.66%和36.31%,TGEV检出率分别为26.75%、13.38%和28.03%;kappa检验结果,环介导间接PCR、Sybr Green实时PCR两种方法对PEDV和TGEV检测结果的符合度均为96.18%(κ≥0.90)【结论】环介导间接PCR可以用于鉴别诊断PEDV/TGEV,是一种快速、准确、灵敏、特异的病原学诊断工具。

减毒沙门氏菌递呈的TGEVS／N融合基因疫苗的口服免疫原性

目的研究携带猪传染性胃肠炎病毒(TGEV)S/N融合基因的重组减毒沙门氏菌的口服免疫原性。方法将真核质粒pVAX-S/N电转化鼠伤寒减毒沙门氏菌SL7207,筛选获得疫苗菌株SL7207(pVAX-S/N)。将菌株SL7207(pVAX-S/N)及对照组SL7207(pVAX-S)以1×109 CFU/只灌胃免疫小鼠,测定免疫小鼠诱导的抗TGEV(和抗沙门氏菌均SL7207)的血清IgG及肠道粘膜IgA抗体动态水平,同时测定42d免疫小鼠的干扰素水平。结果菌株SL7207(pVAX-S/N)构建成功,首免后2～6周可诱导产生抗TGEV(和抗沙门氏菌SL7207)的血清IgG,第4～6周可诱导产生抗TGEV(和抗沙门氏菌均SL7207)的肠道粘膜IgA,SL7207(pVAX-S/N)诱导的IgG和IgA抗体最高滴度均略高于SL7207(pVAX-S),但差异不明显(P>0.05)。SL7207(pVAX-S/N)免疫42d小鼠诱导的干扰素浓度为659.45pg/mL,低于SL7207(pVAXD-S)组。结论 S/N融合基因疫苗SL7207(pVAX-S/N)具有良好的口服免疫原性,但与SL7207(pVAX-S)无明显差异。

TGEV与PEDV核衣壳蛋白双价基因原核质粒的构建与表达

运用DNA重组技术将猪传染性胃肠炎病毒核衣壳基因、猪流行性腹泻病毒核衣壳基因编码最大局部亲水性抗原决定簇基因片段进行串联,克隆到原核表达载体pET-32a(+)中,构建预防仔猪冠状病毒性腹泻双价基因原核表达质粒。将该质粒转化至大肠杆菌BL21(DE3)中,经IPTG诱导后,SDS-PAGE电泳结果显示,双价重组基因表达出约86.8 kD的融合蛋白。Western-blotting检测结果表明,该融合蛋白具有良好的反应原性。

猪传染性胃肠炎病毒S基因RAA检测方法的建立与初步应用

本研究旨在建立一种基于猪传染性胃肠炎病毒(porcine transmissible gastroenteritis virus,TGEV)S基因便捷、高效和特异的由重组酶介导的核酸等温扩增(recombinase-aid amplification,RAA)检测方法。通过基因组序列比对,选择TGEV S基因中特定片段为检测靶标,构建重组质粒pUC57-S,设计并筛选RAA引物和探针;建立RAA检测方法;评价该方法灵敏度、特异性和重复性;运用该方法检测腹泻临床样品,与荧光定量PCR方法比较检测结果的符合率。结果确定最佳引物对F2/R1和探针PF2;该方法在40℃恒温条件下,30 min即可完成反应;荧光型RAA法最低检出限可达1.34×10^(1)copies·μL^(-1);与猪流行性腹泻病毒、猪丁型冠状病毒、猪呼吸道冠状病毒等常见猪源病毒核酸无交叉反应;采用该方法检测107份临床样本,阳性率为5.61%(6/107),与荧光定量PCR法相比较,检测结果一致。本研究成功建立了一种灵敏、特异、可视化的RAA检测方法,可摆脱对昂贵设备、专业人员和检测技术的依赖,为临床检测TGEV提供良好的技术基础。